What if you discovered Wallonia’s nuclear medicine ecosystem? From October 18 to 21, on the occasion of the European Association of Nuclear Medicine (EANM) 2026, the world’s largest congress dedicated to nuclear medicine, the Wallonia Export & Investment Agency (AWEX) will be present to connect international investors with high-potential Walloon companies and technologies. The objective is clear: to create concrete opportunities for partnerships, investment, and co-development in a rapidly growing sector.

By visiting the Walloon pavilion, you will discover an ecosystem recognized for its excellence in life sciences, particularly in nuclear imaging, radiopharmaceuticals, radionuclide therapies, dosimetry, and radioisotope production. Wallonia combines cutting-edge research, innovative companies, and specialized infrastructure, offering an ideal environment to turn medical innovation into clinical and industrial solutions on a global scale.

For you, this is a unique opportunity to identify Wallonia as a strategic European hub for investing, establishing, or expanding activities in nuclear medicine and healthcare. You will benefit from direct access to the European market, tailored institutional support through the Wallonia Export & Investment Agency (AWEX), and a mature, agile ecosystem strongly focused on clinical and industrial innovation.